Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of GERD in Eosinophilic Esophagitis
NCT00728481Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- May 2008
- Primary completion
- Dec 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of esomeprazole, EPI-EE in eosinophilic esophagitis (EoE), sponsored by Mayo Clinic. Started May 2008; status: completed.
02
Drugs
esomeprazoleEPI-EE
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NCT00728481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00728481.